Respiratory Ambulatory Care, Department of Respiratory and Sleep Medicine, Westmead Hospital, Western Sydney Local Health District, New South Wales, Australia (Drs Li, Wheatley, and Cho and Mss Roberts, Leung, Harding, Liu, Boehm, Sausa); Department of Pulmonary and Critical Care Medicine, Jinan Central Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China (Dr Li); Ludwig Engel Centre for Respiratory Research, Westmead Institute for Medical Research, Westmead, New South Wales, Australia (Drs Wheatley and Cho, and Ms Roberts); and Faculty of Medicine and Health, The University of Sydney at Westmead Hospital, New South Wales, Australia (Drs Wheatley and Cho and Ms Roberts).
J Cardiopulm Rehabil Prev. 2022 Jul 1;42(4):252-257. doi: 10.1097/HCR.0000000000000664. Epub 2022 Feb 1.
This study aimed to assess whether there are differences in exercise or health-related quality-of-life (HRQoL) outcomes following twice-weekly supervised sessions of pulmonary rehabilitation (PR) compared with three times weekly over an 8-wk program in patients with chronic obstructive pulmonary disease (COPD).
We conducted a quasi-experimental, single-center observational study using 198 subjects who completed two supervised PR sessions (intervention group) compared with 208 historical controls who completed three weekly sessions. We assessed between-group differences in outcomes after balancing groups using inverse probability of treatment weighting (IPTW) of propensity scores, followed by regression adjustment.
Both groups achieved clinically and statistically significant improvements in exercise and HRQoL following the PR program. After IPTW and regression adjustment, the intervention group had a lower post-PR 6-min walk time by 1.2: 95% CI, -12.9 to 10.5 m ( P = .84), compared with the control group. Although post-PR COPD Assessment Test (CAT) scores decreased in both groups, the intervention group had a higher post-PR CAT score by 1.5: 95% CI, 0.37 to 2.66 a.u. ( P = .01), compared with the control group. All other HRQoL measures failed to reach statistical significance. None of the between-group differences reached minimal clinically important differences for COPD.
Our findings support current international guidelines for twice-weekly supervised PR sessions combined with unsupervised home exercise sessions. We conclude there is no disadvantage in running a PR program for patients with COPD using twice-weekly supervised sessions compared with three times weekly supervised sessions.
本研究旨在评估慢性阻塞性肺疾病(COPD)患者在 8 周的肺康复(PR)计划中,每周接受两次监督的运动与每周三次相比,在运动或健康相关生活质量(HRQoL)结果方面是否存在差异。
我们进行了一项准实验、单中心观察性研究,共纳入 198 名完成两次监督 PR 疗程的患者(干预组)和 208 名完成三次每周疗程的历史对照者。我们使用倾向评分逆概率治疗加权(IPTW)平衡组间差异,然后进行回归调整,评估组间结果的差异。
两组在 PR 计划后在运动和 HRQoL 方面均取得了临床和统计学意义上的显著改善。在 IPTW 和回归调整后,与对照组相比,干预组在 PR 后 6 分钟步行时间减少 1.2:95%CI,-12.9 至 10.5 m(P=.84)。尽管两组在 PR 后 COPD 评估测试(CAT)评分均降低,但与对照组相比,干预组在 PR 后 CAT 评分增加 1.5:95%CI,0.37 至 2.66 a.u.(P=.01)。所有其他 HRQoL 指标均未达到统计学意义。两组间的差异均未达到 COPD 的最小临床重要差异。
我们的研究结果支持目前国际上对于每周两次监督的 PR 疗程与非监督家庭运动相结合的指南建议。我们的结论是,与每周三次监督的 PR 疗程相比,对于 COPD 患者,使用每周两次监督的 PR 疗程没有任何劣势。